OncoNano Medicine, Inc.
Biotechnology company · Dallas, Texas, United States
OncoNano Medicine, Inc. is a biotechnology company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2014. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2025.
OncoNano Medicine at a glance
What does OncoNano Medicine do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2017 to 2023). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $12.7 million sold (2025).
Frequently asked questions about OncoNano Medicine
Where is OncoNano Medicine headquartered?
OncoNano Medicine, Inc. is headquartered in Dallas, Texas, United States.
What does OncoNano Medicine do?
OncoNano Medicine, Inc. is a biotechnology company.
When was OncoNano Medicine founded?
The earliest incorporation on record for OncoNano Medicine, Inc. is in 2014, according to public company registers.
Similar companies
- Spectral MD, Inc.Dallas, Texas, United States
- Taysha Gene Therapies, Inc.Dallas, Texas, United States
- Sonara Health, Inc.Dallas, Texas, United States
- Instil Bio, Inc.Dallas, Texas, United States
- Stingray Therapeutics, Inc.Dallas, Texas, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.